Safety and effect of EMPAGLIFOZIN in patients with HF reduced LVEF in renal function replacement therapy. Adjustments needed for real life
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
Mexican Institute of Social Security (IMSS), Veracruz (Mexico)
7 More presentations in this session
Doctor R. Didier (Dijon, FR)
Doctor D. Bursacovschi (Chisinau, MD)
Doctor D. Bursacovschi (Chisinau, MD)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
